UK markets closed

Ekso Bionics Holdings, Inc. (EKSO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3100+0.0200 (+1.55%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-15,198
-15,198
-15,080
-9,764
-15,825
Depreciation & amortisation
1,698
1,698
887
1,023
620
Stock-based compensation
2,236
2,236
2,732
2,500
2,579
Change in working capital
-583
-583
-2,580
-930
1,123
Accounts receivable
-1,208
-1,208
-67
-1,624
1,754
Inventory
232
232
-1,400
-752
379
Accounts payable
-1,307
-1,307
-102
1,612
-402
Other working capital
-12,211
-12,211
-14,882
-11,215
-8,755
Other non-cash items
-
-
-18
134
385
Net cash provided by operating activities
-12,054
-12,054
-14,688
-11,156
-8,755
Cash flows from investing activities
Investments in property, plant and equipment
-157
-157
-194
-59
-
Acquisitions, net
0
0
-5,000
0
-
Net cash used for investing activities
-157
-157
-5,175
-59
0
Cash flows from financing activities
Debt repayment
-313
-313
0
0
-2,790
Common stock issued
661
661
0
37,295
7,082
Net cash used provided by (used for) financing activities
348
348
0
38,712
10,704
Net change in cash
-11,887
-11,887
-19,881
27,544
1,990
Cash at beginning of period
20,525
20,525
40,406
12,862
10,872
Cash at end of period
8,638
8,638
20,525
40,406
12,862
Free cash flow
Operating cash flow
-12,054
-12,054
-14,688
-11,156
-8,755
Capital expenditure
-157
-157
-194
-59
-
Free cash flow
-12,211
-12,211
-14,882
-11,215
-8,755